Nicotinamide homeostasis: A xenobiotic pathway that is key to development and degenerative diseases
Open Access
- 31 December 2005
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 65 (2) , 353-362
- https://doi.org/10.1016/j.mehy.2005.01.042
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brainTrends in Pharmacological Sciences, 2003
- Divergence between samples of chimpanzee and human DNA sequences is 5%, counting indelsProceedings of the National Academy of Sciences, 2002
- Expression of Nicotinamide N-Methyltransferase (E.C. 2.1.1.1) in the Parkinsonian BrainJournal of Neuropathology and Experimental Neurology, 2002
- METHYLATION PHARMACOGENETICS: Catechol O-Methyltransferase, Thiopurine Methyltransferase, and Histamine N-MethyltransferaseAnnual Review of Pharmacology and Toxicology, 1999
- Substrate specificity of nicotinamide methyltransferase isolated from porcine liverArchives of Biochemistry and Biophysics, 1988
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Evolution at Two Levels in Humans and ChimpanzeesScience, 1975
- Fetal Death from Nicotinamide-Deficient Diet and Its Prevention by Chlorpromazine and ImipramineScience, 1964